Synthesis and immobilization of erythro-C14-ω-aminosphingosine-1- phosphate as a potential tool for affinity chromatography

ChemMedChem

Volumn 3, Issue 2, 2008, Pages 356-360

  Ullrich, Thomas ^a   Ghobrial, Michael ^a   Peters, Carsten ^a   Billich, Andreas ^b   Guerini, Danilo ^c   Nussbaumer, Peter ^a  

^a Novartis Institutes for BioMedical Research   (Austria)

^b Novartis Institutes for BioMedical Research   (Austria)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Immobilization; Metathesis; Phosphorylation; Protectingg roups; Sphingolipids

Indexed keywords

ALKENE; CROSS LINKING REAGENT; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1-PHOSPHATE;

ACYLATION; AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING SITE; CHEMICAL MODEL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ERYTHROCYTE; HUMAN; METABOLISM; METHODOLOGY; PHOSPHORYLATION; STEREOISOMERISM; SYNTHESIS; UMBILICAL VEIN;

ACYLATION; ALKENES; BINDING SITES; CHROMATOGRAPHY, AFFINITY; CROSS-LINKING REAGENTS; ENDOTHELIAL CELLS; ERYTHROCYTES; HUMANS; LYSOPHOSPHOLIPIDS; MODELS, CHEMICAL; PHOSPHORYLATION; SPHINGOSINE; STEREOISOMERISM; UMBILICAL VEINS;

EID: 47649092577     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200700285     Document Type: Article

References (26)

1. a) S. Pyne, N. Pyne, Pharmacol. Ther. 2000, 88, 115-131;
2. b) P. Hanel, P. Andreani, M. H. Graler, FASEB J. 2007, 21, 1202-1209.
3. S. Spiegel, S. Milstien, FEBS Lett. 2000, 476, 55-57.
4. H. Rosen, E. J. Goetzl, Nat. Rev. Immunol. 2005, 5, 560-570.
5. L. Burdine, T. Kodadek, Chem. Biol. 2004, 11, 593-597.
6. P. Ettmayer, A. Billich, T. Baumruker, D. Mechtcheriakowa, H. Schmid, P. Nussbaumer, Bioorg. Med. Chem. Lett. 2004, 14, 1555-1558.
7. Affi-Gel 10 and 15 activated Affinity Media" (Manual), Bio-Rad Laboratories Inc., http://www.bio-rad.com (access date: 10.08.2007).
8. C. Peters, A. Billich, M. Ghobrial, K. Högenauer, T. Ullrich, P. Nussbaumer, J. Org. Chem. 2007, 72, 1842-1845.
9. Y. Watanabe, M. Nakatomi, Tetrahedron Lett. 1998, 39, 1583-1586.
10. A. P. Kozikowski, Q. Ding, S. Spiegel, Tetrahedron Lett. 1996, 37, 3279-3282.
11. T. Hakogi, T. Shigenari, S. Katsumura, T. Sano, T. Kohno, Y. Igarashi, Bioorg. Med. Chem. Lett. 2003, 13, 661-664.
12. P. Nussbaumer, P. Ettmayer, C. Peters, D. Rosenbeiger, K. Högenauer, Chem. Commun. 2005, 5086-5087.
13. Compound 4 was prepared from (S)-N-Boc-2,2-dimethyl- oxazolidine-4-carbaldehyde (P. Garner, J. M. Park, Org. Synth. 1992, 70, 18-28).
14. Prepared as described by: a) D. Bernard, J.-C. Braekman, G. Ferrari, M. Kugler, F. Kunisch, M. Plehiers, M. Vos (Bayer AG), EP1245558A1, 2002 [Chem. Abstr. 2002, 137, 264719];
15. or b) M. H. Hyun, D. H. Kim, Chirality 2004, 16, 294-301.
16. a) T. Yamamoto, H. Hasegawa, T. Hakogi, S. Katsumura, Org. Lett. 2006, 8, 5569-5572;
17. b) A. N. Rai, A. Basu, Org. Lett. 2004, 6), 2861-2863;
18. c) A. N. Rai, A. Basu, J. Org. Chem. 2005, 70, 8228-8230;
19. d) S. Torssell, P. Somfai, Org. Biomol. Chem. 2004, 2, 1643-1646.
20. T. Murakami T. , K. Furusawa, Tetrahedron 2002, 58, 9257-9263.
21. L. Bialy, H. Waldmann, Chem. Eur. J. 2004, 10, 2759-2780.
22. S. K. Shannon, G. Barany, J. Org. Chem. 2004, 69, 4586-4594.
23. P. Ettmayer, T. Baumruker, D. Guerini, D. Mechtcheriakowa, P. Nussbaumer, M. B. Streiff, A. Billich, Bioorg. Med. Chem. Lett. 2006, 16, 84-87.
24. O.-H. Lee, Y.-M. Kim, Y. M. Lee, E.-J. Moon, D.-J. Lee, J.-H. Kim, K.-W. Kim, Y.-G. Kwon, Biochem. Biophys. Res. Commun. 1999, 264, 743-750.
25. Prepared as described by: K. Shimamoto, Y. Shigeri, Y. Yasuda-Kamatani, B. Lebrun, N. Yumoto, T. Nakajima, Bioorg. Med. Chem. Lett. 2000, 10, 2407-2410.
26. T. D. Werry, G. F. Wilkinson, G. B. Willars, Biochem. J. 2003, 374, 281-296.